Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.

Oikawa R, Hosoda C, Nasa Y, Daicho T, Tanoue A, Tsujimoto G, Takagi N, Tanonaka K, Takeo S.

Cardiovasc Res. 2010 Jul 1;87(1):187-94. doi: 10.1093/cvr/cvq034. Epub 2010 Jan 29.

PMID:
20118201
2.

Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc.

Oikawa R, Nasa Y, Ishii R, Kuwaki T, Tanoue A, Tsujimoto G, Takeo S.

Eur J Pharmacol. 2007 Mar 8;558(1-3):144-50. Epub 2006 Dec 12.

PMID:
17224142
3.

V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7807-12. Epub 2006 May 8.

4.

Preferable anesthetic conditions for echocardiographic determination of murine cardiac function.

Kawahara Y, Tanonaka K, Daicho T, Nawa M, Oikawa R, Nasa Y, Takeo S.

J Pharmacol Sci. 2005 Sep;99(1):95-104.

5.

Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.

Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G.

Mol Pharmacol. 2005 Mar;67(3):912-22. Epub 2004 Dec 14.

PMID:
15598970
6.
7.

Insights into alpha1 adrenoceptor function in health and disease from transgenic animal studies.

Tanoue A, Koshimizu TA, Shibata K, Nasa Y, Takeo S, Tsujimoto G.

Trends Endocrinol Metab. 2003 Apr;14(3):107-13. Review.

PMID:
12670735
8.
9.

The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G.

J Clin Invest. 2002 Mar;109(6):765-75.

10.

Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.

Yoshida H, Takahashi M, Tanonaka K, Maki T, Nasa Y, Takeo S.

Br J Pharmacol. 2001 Sep;134(1):150-60.

11.

Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.

Maki T, Nasa Y, Yamaguchi F, Yoshida H, Mori M, Takada T, Horikawa E, Okano K, Takeo S.

Cardiovasc Res. 2001 Aug 15;51(3):608-17.

PMID:
11476752
12.

Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.

Takeo S, Nasa Y, Tanonaka K, Yamaguchi F, Yabe K, Hayashi H, Dhalla NS.

Mol Cell Biochem. 2000 Sep;212(1-2):227-35.

PMID:
11108155
13.

Role of energy metabolism in the preconditioned heart--a possible contribution of mitochondria.

Takeo S, Nasa Y.

Cardiovasc Res. 1999 Jul;43(1):32-43. Review.

PMID:
10536688
14.

Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril.

Yamaguchi F, Kawana K, Tanonaka K, Kamano I, Igarashi T, Gen E, Fujimoto Y, Maki T, Sanbe A, Nasa Y, Takeo S.

Br J Pharmacol. 1999 Apr;126(7):1585-92.

15.

Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats.

Takeo S, Nasa Y, Tanonaka K, Yabe K, Nojiri M, Hayashi M, Sasaki H, Ida K, Yanai K.

Mol Cell Biochem. 1998 Nov;188(1-2):199-208.

PMID:
9823025
16.

Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.

Toyoshima H, Nasa Y, Hashizume Y, Koseki Y, Isayama Y, Kohsaka Y, Yamada T, Takeo S.

J Cardiovasc Pharmacol. 1998 Oct;32(4):543-51.

PMID:
9781922
18.

Effects of the antihypertensive agent, cicletanine, on noradrenaline release and vasoconstriction in perfused mesenteric artery of SHR.

Nasa Y, Yoshida H, Urata M, Uchibayashi K, Tsunoda Y, Kamigata K, Takeo S.

Br J Pharmacol. 1998 Feb;123(3):427-34.

19.

The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.

Toyoshima H, Nasa Y, Kohsaka Y, Isayama Y, Yamaguchi F, Sanbe A, Takeo S.

Br J Pharmacol. 1998 Jan;123(2):344-52.

20.
21.

Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction.

Nasa Y, Sakamoto Y, Sanbe A, Sasaki H, Yamaguchi F, Takeo S.

Mol Cell Biochem. 1997 Nov;176(1-2):179-89.

PMID:
9406160
22.

Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.

Nasa Y, Yabe K, Takeo S.

J Cardiovasc Pharmacol. 1997 Apr;29(4):436-43.

PMID:
9156351
23.
25.

Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart.

Yamaguchi F, Nasa Y, Yabe K, Ohba S, Hashizume Y, Ohaku H, Furuhama K, Takeo S.

Heart Vessels. 1997;12(2):74-83.

PMID:
9403311
26.

beta-Adrenoreceptor antagonistic actions and mutagenicities of R(+)- and S(-)-enantiomers of N-desisopropylpropranolol and its N-acetyl conjugate.

Ono Y, Wu X, Noda A, Noda H, Takeo S, Nasa Y, Isayama Y, Imai M, Sera N.

Biol Pharm Bull. 1997 Jan;20(1):61-5.

PMID:
9013808
27.

Impairment of cGMP- and cAMP-mediated vasorelaxations in rats with chronic heart failure.

Nasa Y, Toyoshima H, Ohaku H, Hashizume Y, Sanbe A, Takeo S.

Am J Physiol. 1996 Dec;271(6 Pt 2):H2228-37.

PMID:
8997278
28.

Effects of long-term treatment with trandolapril on augmented vasoconstriction in rats with chronic heart failure.

Okumura Y, Nasa Y, Sanbe A, Toga W, Takeo S.

J Card Fail. 1996 Dec;2(4):301-10.

PMID:
8989645
29.

The effects of long-term treatment with eicosapentaenoic acid and docosahexaenoic acid on hypoxia/rexoygenation injury of isolated cardiac cells in adult rats.

Hayashi M, Nasa Y, Tanonaka K, Sasaki H, Miyake R, Hayashi J, Takeo S.

J Mol Cell Cardiol. 1995 Sep;27(9):2031-41.

PMID:
8523462
30.

Reperfusion at reduced flow rates enhances postischemic contractile recovery of perfused heart.

Takeo S, Liu JX, Tanonaka K, Nasa Y, Yabe K, Tanahashi H, Sudo H.

Am J Physiol. 1995 Jun;268(6 Pt 2):H2384-95.

PMID:
7611491
32.

Hyperresponsiveness of cardiac muscles to histamine in reserpine-treated guinea pigs.

Okazaki N, Tanonaka K, Nasa Y, Takagi N, Yamasaki T, Yoshida S, Takeo S.

Jpn Heart J. 1994 Sep;35(5):661-71.

PMID:
7830330
33.

Protective effect of crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart.

Nasa Y, Hashizume H, Hoque AN, Abiko Y.

Arzneimittelforschung. 1993 Sep;43(9):945-9.

PMID:
8240455
34.

Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts.

Hoque AN, Nasa Y, Abiko Y.

Eur J Pharmacol. 1993 May 19;236(2):269-77.

PMID:
8319754
35.

Effects of naftidrofuryl oxalate on microsphere embolism-induced changes in tricarboxylic acid cycle intermediates of rats.

Miyake K, Tanonaka K, Nasa Y, Takagi N, Tsuchiya T, Yoshizawa M, Fujioka Y, Takeo S.

Eur J Pharmacol. 1993 Apr 22;235(1):75-81.

PMID:
7686106
36.

Cardioprotective effect of pindolol in ischemic-reperfused isolated rat hearts.

Nasa Y, Hoque AN, Ichihara K, Abiko Y.

Eur J Pharmacol. 1992 Mar 24;213(2):171-81.

PMID:
1521558
37.

Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.

Nasa Y, Ichihara K, Yoshida R, Abiko Y.

Br J Pharmacol. 1992 Mar;105(3):696-702.

38.

The inhibitory effect of bevantolol on the accumulation of non-esterified fatty acids during ischaemia in the dog heart in situ.

Miura I, Nasa Y, Ichihara K, Abiko Y.

Clin Exp Pharmacol Physiol. 1991 Apr;18(4):259-62.

PMID:
1676940
39.

Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.

Nasa Y, Ichihara K, Abiko Y.

J Pharmacol Exp Ther. 1990 Nov;255(2):680-9.

PMID:
2243348
40.

Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs.

Sakai K, Ichihara K, Nasa Y, Kamigaki M, Abiko Y.

Arch Int Pharmacodyn Ther. 1990 Sep-Oct;307:92-108.

PMID:
2095718
41.
42.

Changes in myocardial nonesterified fatty acids during ischemia and reperfusion in isolated, perfused, working rat hearts.

Hara Y, Nakamura K, Nasa Y, Ichihara K, Abiko Y.

Heart Vessels. 1990;6(1):21-30.

PMID:
2127049

Supplemental Content

Support Center